Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The management of menopausal symptoms in women following treatment for cancer at a specialist menopause service.

Post reproductive health - 1 Sept 2021

Chakrabarti R, Holloway D, Bruce D, Rymer J

Abstract excerpt

OBJECTIVE: The aim of this study was to identify prescribing patterns at a specialist menopause service in a central London teaching hospital for women following treatment for a malignancy. STUDY DESIGN: This was a prospective cohort study with data collected over a seven-month period from December 2019 to June 2020. All women reviewed at the specialist menopause services following treatment of a malignancy, BRCA...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Breast Neoplasms
Share to Menopause
Share to Mutation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Neoplasm Recurrence, Local

Source

Identifiers

PMID: 33823682
DOI: 10.1177/20533691211000548

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The management of menopausal symptoms in women following treatment for cancer at a specialist menopause service.PMID 33823682Read ↗

Hormone replacement therapy in gynecological cancer survivors and BRCA mutation carriers: a MITO group survey.Semantic proximity Read ↗

Risk-Reducing Salpingo-Oophorectomy and the Use of Hormone Replacement Therapy Below the Age of Natural Menopause: Scientific Impact Paper No. 66 October 2021: Scientific Impact Paper No. 66.Semantic proximity Read ↗

Uptake of risk-reducing surgery in BRCA gene carriers in Wales, UK.Semantic proximity Read ↗

Hormonal management after risk-reducing surgery in BRCA-mutated triple-negative breast cancer survivors.Semantic proximity Read ↗

Preventing breast and ovarian cancers in high-risk BRCA1 and BRCA2 mutation carriers.Semantic proximity Read ↗

Hormone replacement therapy in BRCA mutation carriers and risk of ovarian, endometrial, and breast cancer: a systematic review.Semantic proximity Read ↗

Collateral effects of the COVID-19 pandemic on endocrine treatments for breast and prostate cancer in the UK: implications for bone healthSemantic proximity Read ↗

Managing symptoms and maximizing quality of life after preventive interventions for cancer risk reduction.Semantic proximity Read ↗

A rapid evidence map of womens healthSemantic proximity Read ↗

Hormone therapy (HT) in women with gynecologic cancers and in women at high risk for developing a gynecologic cancer: A Society of Gynecologic Oncology (SGO) clinical practice statement: This practice statement has been endorsed by The North American Menopause Society.Semantic proximity Read ↗

Risks and benefits of therapy with menopausal hormones versus selective estrogen-receptor modulators in peri- and postmenopausal women at increased breast cancer risk.Semantic proximity Read ↗

Factors associated with use of hormone therapy after preventive oophorectomy in BRCA mutation carriers.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.